Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

25 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

367

146 (4%)

70 (29%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185957
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185961
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185964
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-10-20 2023-11-06 207683
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207686
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-10-20 2023-12-22 207689
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Actual shortage 2025-03-13 2025-04-17 252564
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185967
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-SOTALOL 80MG TABLET Resolved 2023-01-06 2023-02-16 180086
APO-SOTALOL 160MG TABLET Resolved 2023-01-06 2023-02-16 180093
APO-SOTALOL 160MG TABLET Resolved 2023-03-09 2023-06-29 186569
APO-SOTALOL 80MG TABLET Resolved 2023-04-14 2023-06-29 189635
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-08-08 60772
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
APO-SILDENAFIL 100MG TABLET Discontinued 2018-09-08 2018-09-15 60784
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272